At a glance
- Originator Ontogen
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute asthma; Chronic obstructive pulmonary disease; Reperfusion injury
Most Recent Events
- 03 Feb 2003 No development reported - Preclinical for Acute asthma in USA (unspecified route)
- 03 Feb 2003 No development reported - Preclinical for Chronic obstructive pulmonary disease in USA (unspecified route)
- 03 Feb 2003 No development reported - Preclinical for Reperfusion injury in USA (unspecified route)